aTyr Pharma Inc logo

aTyr Pharma Inc

$ 2.85 +0.11 (+4.01%) 08:08 PM EST
P/E:
At Loss
P/B:
0.93
Market Cap:
$ 81.58M
Enterprise V:
$ -8.85M
Volume:
101.61K
Avg Vol (2M):
137.71K
Also Trade In:
Volume:
101.61K
Market Cap $:
81.58M
PE Ratio:
At Loss
Avg Vol (2-Month):
137.71K
Enterprise Value $:
-8.85M
PB Ratio:
0.93
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. Its focus is on the extracellular functionality and signaling pathways of tRNA synthetases. It's lead clinical product candidate, ATYR1923, is a selective modulator of Neuropilin-2 (NRP2) that downregulates both the innate and adaptive immune responses in inflammatory disease states. It is developing ATYR1923 as a potential disease-modifying therapy for patients with interstitial lung diseases (ILDs), a group of rare immune-mediated disorders that cause progressive fibrosis of the lung interstitium and remain a high unmet medical need.
Name Current Vs Industry Vs History
Cash-To-Debt 69.51
Equity-to-Asset 0.9
Debt-to-Equity 0.02
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -2.09
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.88
9-Day RSI 32.51
14-Day RSI 34.22
6-1 Month Momentum % -39.2
12-1 Month Momentum % -60.65

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.08
Quick Ratio 10.08
Cash Ratio 9.56

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -133.4
Name Current Vs Industry Vs History
ROE % -45.02
ROA % -41.7
ROIC % -1287.06
ROC (Joel Greenblatt) % -2050.91
ROCE % -45.46

Financials (Next Earnings Date:2022-11-10 Est.)

LIFE's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LIFE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.61
Beta 1.47
Volatility % 88.82
14-Day RSI 34.22
14-Day ATR ($) 0.194257
20-Day SMA ($) 3.206
12-1 Month Momentum % -60.65
52-Week Range ($) 2.6 - 9.95
Shares Outstanding (Mil) 28.63

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

aTyr Pharma Inc Filings

Document Form Filing Date
No Filing Data

aTyr Pharma Inc Analysis

Share your research

Headlines

See More
No news.